Voloridge Investment Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-725,508
| Closed | -$13.3M | – | 1150 |
|
|
2024
Q4 | $13.3M | Sell |
725,508
-583,485
| -45% | -$10.7M | 0.05% | 490 |
|
|
2024
Q3 | $20.1M | Sell |
1,308,993
-292,223
| -18% | -$4.49M | 0.07% | 372 |
|
|
2024
Q2 | $26M | Buy |
1,601,216
+243,243
| +18% | +$3.95M | 0.1% | 291 |
|
|
2024
Q1 | $25.1M | Buy |
1,357,973
+75,796
| +6% | +$1.4M | 0.09% | 276 |
|
|
2023
Q4 | $40.1M | Buy |
1,282,177
+237,676
| +23% | +$7.44M | 0.16% | 175 |
|
|
2023
Q3 | $21.8M | Buy |
1,044,501
+529,927
| +103% | +$11M | 0.11% | 267 |
|
|
2023
Q2 | $12.3M | Buy |
514,574
+298,642
| +138% | +$7.15M | 0.06% | 408 |
|
|
2023
Q1 | $4.06M | Sell |
215,932
-289,172
| -57% | -$5.44M | 0.02% | 747 |
|
|
2022
Q4 | $8.04M | Sell |
505,104
-199,461
| -28% | -$3.18M | 0.04% | 501 |
|
|
2022
Q3 | $11.5M | Sell |
704,565
-337,690
| -32% | -$5.52M | 0.06% | 407 |
|
|
2022
Q2 | $14.7M | Buy |
1,042,255
+617,594
| +145% | +$8.7M | 0.08% | 336 |
|
|
2022
Q1 | $10.3M | Buy |
424,661
+98,748
| +30% | +$2.39M | 0.06% | 401 |
|
|
2021
Q4 | $7.61M | Sell |
325,913
-443,759
| -58% | -$10.4M | 0.04% | 551 |
|
|
2021
Q3 | $12.8M | Buy |
769,672
+169,240
| +28% | +$2.81M | 0.08% | 345 |
|
|
2021
Q2 | $14.6M | Sell |
600,432
-38,932
| -6% | -$950K | 0.1% | 263 |
|
|
2021
Q1 | $16.5M | Buy |
+639,364
| New | +$16.5M | 0.12% | 222 |
|
|
2019
Q4 | – | Sell |
-104,352
| Closed | -$3.76M | – | 1049 |
|
|
2019
Q3 | $3.76M | Buy |
104,352
+92,192
| +758% | +$3.32M | 0.07% | 315 |
|
|
2019
Q2 | $325K | Sell |
12,160
-21,618
| -64% | -$578K | 0.01% | 634 |
|
|
2019
Q1 | $907K | Buy |
+33,778
| New | +$907K | 0.03% | 508 |
|